Avid’s Amyvid Recommended for Approval In Europe as Diagnostic Tool for Alzheimer’s Disease

By WebmasterOctober 19, 2012November 1st, 2024No Comments

Avid’s Amyvid Recommended for Approval In Europe as Diagnostic Tool for Alzheimer’s Disease
Read more here

Previous PostQR's Posiphen® Restores Brain Function, Cognition and Memory in Transgenic Alzheimer Mice
Next PostAmyvid™ (Florbetapir F 18 Injection) Recommended for Approval in Europe as a Diagnostic Tool for PET Imaging of Beta-Amyloid Plaque Density